Pharma Stocks

Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.

Get Started Live Share Market

List of Pharma Stocks

Pharma Stocks More Collections >

The Pharma Stocks collection features companies involved in the research, development, manufacturing, and distribution of pharmaceuticals. This sector is charac...Learn More

More Collections >

Filter

Reset Filter

Price

Market Cap

Last 1 Yr return

Analyst Recommendation

Dividend Yield

Index

Reset Filter

Apply

Name	Price	M Cap	Analyst Rating	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Div Yld	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Sun Pharmaceuticals Industries Ltd	₹1,801.05	Large Cap	BUY	2047.11	29.19%	42.81%	134.18%	306.83%	39.26	55.9	16.41	0.48	0.83%	3030.67 Cr	5.55%	12.7%	322.31%	13264.22	5.91%	10.51%	44.77%	19.89%	-0.33%	1.99%	191.7%	Basic Materials	429253.02	12.05%	12.22%	40.21	1732860
Divis Laboratories Ltd	₹5,849.75	Large Cap	HOLD	5512.44	43.86%	57.48%	32.64%	218.17%	84.69	55.9	6.75	0.5	0.87%	510 Cr	18.6%	-12.28%	-19.37%	2338	10.39%	1%	12.56%	20.4%	7.44%	-13.15%	-28.37%	Basic Materials	155230.1	12.04%	16.27%	60.38	280887
Cipla Ltd	₹1,472.40	Large Cap	BUY	1629.72	5.61%	19.23%	62.32%	210.14%	26.14	55.9	4.31	0.26	0.87%	1306.02 Cr	11.03%	46.55%	73.04%	6961.22	5.08%	13.28%	34.52%	16.12%	5.66%	29.37%	28.64%	Basic Materials	117172.68	15.5%	20.1%	51.47	2499842
Torrent Pharmaceuticals Ltd	₹3,381.90	Large Cap	BUY	3591.55	43.86%	57.48%	120.13%	271.23%	63.14	55.9	12.89	0.4	1.08%	453 Cr	-0.88%	33.02%	32.31%	2831	0.57%	11.51%	34.02%	15.44%	-1.44%	19.28%	-1.28%	Basic Materials	114277.74	20.43%	20.4%	48.94	348736
Mankind Pharma Ltd	₹2,805.95	Large Cap	BUY	2814.88	24.33%	37.95%	87.15%	87.15%	50.97	55.9	9.56	0.32	NA	658.88 Cr	21.33%	48.26%	50.17%	3076.51	6.33%	18.12%	66.3%	18.79%	14.1%	25.52%	-9.7%	Pharmaceuticals	106648.25	20.95%	25.77%	48.47	2380266
Dr Reddys Laboratories Ltd	₹1,275.40	Large Cap	HOLD	1336.87	-2.04%	11.58%	36.78%	117.1%	19.81	55.9	4.22	0.47	0.65%	1341.9 Cr	-3.63%	23.75%	185.81%	8016.1	4.48%	13.54%	47.06%	19.91%	-7.76%	8.99%	94.35%	Basic Materials	104105.27	19.42%	25.4%	66.88	2823838
Zydus Lifesciences Ltd	₹979.55	Mid Cap	HOLD	1083.36	28.89%	42.51%	117.86%	274.62%	23.15	55.9	6.43	0.63	0.3%	898.1 Cr	-38.64%	92.98%	80.31%	5113.6	-15.43%	13.4%	35.71%	19.72%	-27.44%	70.18%	32.86%	Basic Materials	97594.63	23.45%	22.73%	38.31	806464
Lupin Ltd	₹2,099.10	Mid Cap	HOLD	2218.36	49.15%	62.77%	133.93%	167.14%	35.8	55.9	3.58	0.43	0.49%	859.48 Cr	6.7%	332.35%	57.63%	5497.01	-0.31%	20.25%	31.97%	9.67%	7.03%	259.55%	19.44%	Basic Materials	93395.05	11.92%	13.96%	42.47	1002541
Aurobindo Pharma Ltd	₹1,247.55	Mid Cap	BUY	1537.14	5.12%	18.74%	76.79%	167.35%	20.32	55.9	3.24	0.6	0.41%	816.95 Cr	-11.03%	64.4%	-40.59%	7646.21	2.53%	16.68%	17.06%	10.93%	-13.22%	40.89%	-49.25%	Basic Materials	71118.3	10.35%	11.74%	54.09	2270635
Alkem Laboratories Ltd	₹5,493.25	Mid Cap	HOLD	5775.29	-3.66%	9.96%	59.84%	157.31%	30.66	55.9	5.6	0.49	0.81%	701.96 Cr	27.57%	79.92%	11.97%	3414.67	12.63%	9.21%	42.89%	14.3%	13.27%	64.75%	-21.64%	Basic Materials	64465.26	17.56%	17.28%	151.52	241974
Abbott India Ltd	₹28,109.60	Mid Cap	BUY	28117.14	8.84%	22.89%	56.25%	112.23%	0	55.9	15.48	0.54	NA	0 Cr	0%	16.35%	0%	NA	0%	14.52%	0%	14.18%	0%	1.6%	0%	Basic Materials	59490.33	34.88%	44.71%	35.67	5681
Glenmark Pharmaceuticals Ltd	₹1,524.70	Mid Cap	BUY	1608.07	71.64%	85.26%	208.31%	327.95%	-50.03	55.9	1.18	0.92	0.26%	354.49 Cr	4.19%	-479.84%	-247.77%	3400.5	5.5%	1.98%	7.94%	-12.14%	-1.24%	-472.45%	-236.9%	Basic Materials	42726.11	6.98%	9.75%	-50.8	258848

Why to invest in Pharma Stocks

Research and Development Focus: Pharma stocks are driven by a strong emphasis on research and development for the creation of innovative drugs.
Global Health Impact: Investing in pharma stocks aligns with contributing to global health and addressing medical challenges.
Stable Revenue Streams: These stocks often provide stable revenues due to consistent demand for medications and healthcare solutions.
Regulatory Resilience: Pharma stocks showcase resilience to regulatory changes, contributing to a stable investment environment.
Defensive Characteristics: Considered defensive, pharma stocks can offer stability during economic downturns.

Advantages of investing in Pharma Stocks

Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.

Points to consider before investing in Pharma Stocks

Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.

Check More Stocks

Name	Price	M Cap	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Adani Power Ltd	₹521.15	LARGE CAP	-16.36%	-2.73%	440.27%	756.49%	17	28.07	6.88	1.47	3297.52 Cr	-15.72%	94.18%	1540.09%	13338.88	-10.81%	29.86%	92.02%	41.37%	-5.51%	49.53%	754.11%	Utilities	202335.02	55.41%	30.81%	54	2975529
Tata Motors Ltd	₹755.70	LARGE CAP	-6.92%	6.7%	74.42%	346.08%	8.92	36.3	12.63	1.08	3450 Cr	-39.39%	1082.46%	-344.36%	100534	-6.32%	26.58%	75.32%	7.26%	-35.3%	834.16%	-239.39%	Consumer Cyclical	287035.71	19.5%	14.69%	82.99	19085263
Adani Wilmar Ltd	₹299.10	MID CAP	-31.04%	-17.42%	12.92%	12.92%	40.44	137.94	5.04	0.94	281.91 Cr	-9.54%	-69.17%	-73.83%	14460.45	2.06%	-11.9%	38.21%	0.33%	-11.36%	-65.01%	-81.06%	Edible Oil	39367.26	3.42%	9.6%	1.31	774279
Infosys Ltd	₹1,979.15	LARGE CAP	12.73%	26.35%	9.88%	169.86%	30.42	42.28	7.66	0.7	6516 Cr	2.23%	8.88%	35.14%	40986	4.25%	4.7%	52.95%	17.08%	-1.94%	3.99%	-11.64%	Technology	820733.13	36.58%	45.07%	63.37	3064095
Tata Steel Ltd	₹144.46	LARGE CAP	-6.97%	6.65%	35.77%	227.52%	62.89	25.55	1.43	1.42	758.84 Cr	-17.39%	-160.8%	-159.95%	53489.73	-1.7%	-5.83%	46.63%	-2.14%	-15.96%	-164.56%	-140.88%	Industrials	181860.02	7.79%	13.67%	-3.94	19850229
Yes Bank Ltd	₹20.62	MID CAP	-21.69%	-8.07%	64.39%	-55.17%	36.02	16.31	1.62	1.25	566.59 Cr	9.8%	74.66%	-136.84%	9225.45	2.55%	23.98%	42.4%	3.9%	7.08%	40.88%	-125.87%	Financial Services	65709.36	2.45%	NA	0.45	86755291
Zomato Ltd	₹291.90	LARGE CAP	117.26%	130.88%	134.53%	135.56%	346.06		6.95	0.69	176 Cr	-30.43%	-136.15%	-142.99%	4799	14.1%	71.13%	507.58%	2.9%	-39.03%	-121.12%	-107.08%	Technology	286422.41	5.15%	5.18%	0.4	28348122
ITC Ltd	₹470.50	LARGE CAP	-9.66%	3.96%	121.07%	91.54%	28.58	29.24	7.41	0.63	5054.43 Cr	-2.37%	6.54%	55.06%	20581.57	12.22%	-0.08%	43.85%	29.28%	-13%	6.63%	7.79%	Consumer Defensive	587445.17	29.21%	37.4%	16.62	12365167
Wipro Ltd	₹312.60	LARGE CAP	25.11%	38.73%	-7.25%	148.77%	27.51	42.28	4.34	1.05	3226.6 Cr	6.26%	-2.24%	2.25%	22301.6	1.54%	-0.8%	44.93%	12.38%	4.65%	-1.45%	-29.45%	Technology	323264.87	15.13%	19.03%	10.635	10965226
HDFC Bank Ltd	₹1,810.70	LARGE CAP	-2.9%	10.72%	28.59%	41.85%	20.49	16.31	2.5	0.96	17825.91 Cr	8.2%	39.27%	101.24%	121456.74	3.81%	99.35%	161.73%	15.7%	4.23%	-30.13%	-23.11%	Financial Services	1401495.96	16.88%	NA	86.15	11711156

Frequently Asked Questions

Pharma stocks represent publicly traded companies involved in researching, developing, manufacturing, and marketing pharmaceutical drugs and treatments. These companies play a vital role in advancing healthcare and stand to benefit from successful product launches and growing healthcare needs.

High R&D Costs: Developing new drugs is expensive and time-consuming, with a high risk of failure during clinical trials, potentially impacting stock prices.
Regulatory Hurdles: Strict government regulations can delay drug approvals, hindering a company's ability to bring products to market.
Patent Expiry: Once a drug's patent expires, generic competition can significantly reduce profitability.
Economic Downturns: Healthcare spending can be impacted by economic downturns, potentially affecting pharma companies' revenues

Strong R&D Pipeline: Look for companies with a robust pipeline of drugs in various stages of development.
Focus on Innovation: Companies prioritising innovative therapies or addressing unmet medical needs can be attractive.
Financials: Evaluate a company's financial health, considering factors like profitability, debt levels, and cash flow.
Regulatory Environment: Understanding the regulatory landscape in the company's target markets is crucial.

Diversification is crucial when investing in pharmaceutical sector stocks. While the industry presents significant growth opportunities, it also entails considerable risks and uncertainties, including patent expirations, regulatory hurdles, and potential clinical trial failures, among others.

By spreading investments across multiple pharmaceutical companies, investors can mitigate risk and lessen the potential negative impact on overall returns. This approach allows for a balance between potential gains and losses, ultimately improving the performance and stability of returns.

Government policy changes can have a significant impact on pharmaceutical sector stocks. In particular, government decisions related to reimbursement rates, intellectual property rights, and drug pricing can greatly influence the market potential and profitability of pharmaceutical companies.